title: Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
abstract: One of the candidate proteins for a mucosal vaccine antigen against Streptococcus pneumoniae is PsaA (pneumococcal surface antigen A). Vaccines targeting mucosal immunity may raise concerns as to possible alterations in the normal microbiota, especially in the case of PsaA, which was shown to have homologs with elevated sequence identity in other viridans group streptococci. In this work, we demonstrate that intranasal immunization with a cholera toxin B subunit-PsaA fusion protein is able to protect mice against colonization with S. pneumoniae but does not significantly alter the natural oral or nasopharyngeal microbiota of mice.
authors.affiliation: Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
authors.forename: F C
authors.initials: FC
authors.lastname: Pimenta
authors.forename: E N
authors.initials: EN
authors.lastname: Miyaji
authors.forename: A P M
authors.initials: AP
authors.lastname: Arêas
authors.forename: M L S
authors.initials: ML
authors.lastname: Oliveira
authors.forename: A L S S
authors.initials: AL
authors.lastname: de Andrade
authors.forename: P L
authors.initials: PL
authors.lastname: Ho
authors.forename: S K
authors.initials: SK
authors.lastname: Hollingshead
authors.forename: L C C
authors.initials: LC
authors.lastname: Leite
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood*; D001426:Bacterial Proteins / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D002772:Cholera Toxin / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D005260:Female; D006094:Gram-Positive Bacteria / Q000254:growth & development / Q000302:isolation & purification; D007114:Immunization; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D051379:Mice; D008810:Mice, Inbred C57BL; D009055:Mouth / Q000382:microbiology; D009305:Nasopharynx / Q000382:microbiology; D011008:Pneumococcal Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage* / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000254:growth & development / Q000276:immunology*
chemical_list: D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D022242:Pneumococcal Vaccines; D011993:Recombinant Fusion Proteins; C051592:pneumococcal surface protein A; D002772:Cholera Toxin